Stem Pharm's synthetic biomaterials support the optimization of cell expansion.
Stem Pharm has raised $75K in total funding. The most recent round was Grant. The last funding was announced in February 2025.
Stem Pharm's investors include National Institutes of Health, Wisconsin Economic Development, Small Business Innovation Research, Merck Digital Sciences Studio, SBIR Advance.
Stem Pharm is headquartered in Madison, United States.
Stem Pharm's synthetic biomaterials support the optimization of cell expansion.
Stem Pharm is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Stem Pharm — Funding & Investors." VCBacked, February 23, 2025, https://www.vcbacked.co/company/stem-pharm. Accessed July 20, 2026.
VCBacked. (2025). Stem Pharm — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/stem-pharm
{{cite web |title=Stem Pharm — Funding & Investors |url=https://www.vcbacked.co/company/stem-pharm |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated